Class information for:
Level 1: POLYVALENT ANTIGEN//AUTOLOGOUS ANTIBODY//B700

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
12231 857 32.3 60%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
701 12232 RADIOIMMUNOTHERAPY//BISPECIFIC ANTIBODIES//EP CAM

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ.
in class
1 POLYVALENT ANTIGEN Author keyword 4 56% 1% 5
2 AUTOLOGOUS ANTIBODY Author keyword 2 67% 0% 2
3 B700 Author keyword 2 67% 0% 2
4 BL6 MELANOMA Author keyword 2 67% 0% 2
5 R24 Author keyword 2 67% 0% 2
6 ANTIMELANOMA ANTIBODIES Author keyword 1 40% 0% 2
7 GM2 Author keyword 1 15% 1% 6
8 AUTOLOGOUS ANTIBODIES Author keyword 1 50% 0% 1
9 CANC UK CLIN ONCOL Address 1 50% 0% 1
10 DYSPLASTIC MELANOCYTIC NEVUS Author keyword 1 50% 0% 1

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ.
in class		 LCSH search Wikipedia search
1 POLYVALENT ANTIGEN 4 56% 1% 5 Search POLYVALENT+ANTIGEN Search POLYVALENT+ANTIGEN
2 AUTOLOGOUS ANTIBODY 2 67% 0% 2 Search AUTOLOGOUS+ANTIBODY Search AUTOLOGOUS+ANTIBODY
3 B700 2 67% 0% 2 Search B700 Search B700
4 BL6 MELANOMA 2 67% 0% 2 Search BL6+MELANOMA Search BL6+MELANOMA
5 R24 2 67% 0% 2 Search R24 Search R24
6 ANTIMELANOMA ANTIBODIES 1 40% 0% 2 Search ANTIMELANOMA+ANTIBODIES Search ANTIMELANOMA+ANTIBODIES
7 GM2 1 15% 1% 6 Search GM2 Search GM2
8 AUTOLOGOUS ANTIBODIES 1 50% 0% 1 Search AUTOLOGOUS+ANTIBODIES Search AUTOLOGOUS+ANTIBODIES
9 DYSPLASTIC MELANOCYTIC NEVUS 1 50% 0% 1 Search DYSPLASTIC+MELANOCYTIC+NEVUS Search DYSPLASTIC+MELANOCYTIC+NEVUS
10 H 2KB GENE 1 50% 0% 1 Search H+2KB+GENE Search H+2KB+GENE

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 FORMALINIZED EXTRACELLULAR ANTIGENS 8 75% 1% 6
2 ANTIGENIC SYSTEMS 8 100% 1% 5
3 B700 8 100% 1% 5
4 GD3 GANGLIOSIDE 5 15% 4% 31
5 TYR GLN ILE 4 75% 0% 3
6 DISIALOGANGLIOSIDE GD3 3 43% 1% 6
7 MOAB HMSA 2 3 100% 0% 3
8 SYNGENEIC MONOCLONAL ANTIBODIES 3 100% 0% 3
9 ANTIGANGLIOSIDE GM2 ANTIBODY 3 60% 0% 3
10 NAMALWA KJM 1 2 67% 0% 2

Journals

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
HUMAN-MELANOMA - DEVELOPMENT AND PROGRESSION 1990 144 28 43%
Ganglioside vaccines with emphasis on GM2 1998 52 43 33%
MELANOMA ANTIGENS - IMMUNOLOGICAL AND BIOLOGICAL CHARACTERIZATION AND CLINICAL-SIGNIFICANCE 1988 93 122 54%
BIOLOGY OF TUMOR PROGRESSION IN HUMAN MELANOCYTES 1987 216 114 45%
HUMAN-TUMOR ANTIGENS 1987 102 100 42%
Glycans as targets for therapeutic antitumor antibodies 2012 7 139 14%
TUMOR GANGLIOSIDES AS TARGETS FOR ACTIVE SPECIFIC IMMUNOTHERAPY OF MELANOMA IN MAN 1994 24 74 28%
HUMAN HIGH-MOLECULAR-WEIGHT MELANOMA-ASSOCIATED ANTIGEN MIMICRY BY MOUSE ANTIIDIOTYPIC MONOCLONAL-ANTIBODIES MK2-23 - EXPERIMENTAL STUDIES AND CLINICAL-TRIALS IN PATIENTS WITH MALIGNANT-MELANOMA 1993 9 71 44%
ANTIGENS OF MELANOCYTES AND MELANOMA 1991 13 31 48%
ANTIGENS AND ANTIBODIES IN MALIGNANT-MELANOMA 1994 25 55 20%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ.
in class
1 CANC UK CLIN ONCOL 1 50% 0.1% 1
2 GLYCOLIPID IMMUNOTHER Y 1 50% 0.1% 1
3 IMMUNOL MONITORING DIAGNOST 1 50% 0.1% 1
4 BIOENGN ADV CLIN 0 33% 0.1% 1
5 INTERDISCIPLINARY GENE THER Y CINTERGEN 0 33% 0.1% 1
6 GUYS ST THOMASS NHS TRUST 0 25% 0.1% 1
7 LIFE SCI TECHNOL BIOMED ENGN 0 14% 0.1% 1
8 IST CHIM COMPOSTI ORGANO METALLICI 0 13% 0.1% 1
9 FIORGEN FDN 0 11% 0.1% 1
10 INSERM U331 0 11% 0.1% 1

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000152447 NEUGCGM3//N GLYCOLYL GM3//CMP N ACETYLNEURAMINIC ACID HYDROXYLASE
2 0.0000139906 BOWMAN GRAY MED MICROBIOL IMMUNOL//C 14 LEUCINE INCORPORATION//SOCIAL SCI STAT
3 0.0000120413 IMMUNOCYTOKINES//IMMUNOCYTOKINE//PHILOCHEM AG
4 0.0000114236 MONOCLONAL ANTIBODY HUMAN//HETEROHYBRIDOMA//IDIOTYPE ACTIVITY
5 0.0000106318 ANTIBODY IMMUNOCONJUGATES AND RADIOPHARMACEUTICALS//RADIOIMMUNOGUIDED SURGERY//IMMUNOSCINTIGRAPHY
6 0.0000103330 GANGLIOSIDES//GANGLIOSIDE//GM1 GANGLIOSIDE
7 0.0000102756 ANTIGEN PROCESSING MACHINERY//BIOQUIM BIOL MOL INMUNOL 3//HLA CLASS I
8 0.0000101920 EP CAM//TROP2//EDRECOLOMAB
9 0.0000086802 ANTI IDIOTYPIC ANTIBODY//ANTI ANTI IDIOTYPIC ANTIBODY//INTERNAL IMAGE
10 0.0000085600 BIOCHEMOTHERAPY//METASTATIC MELANOMA//DACARBAZINE